COLISTIMETHATE SODIUM 150 mg/4mL

Colistimethate Sodium 150 mg/4mL is a lyophilized powder for solution, used for its antimicrobial properties. This injection is commonly administered intramuscularly or intravenously for specific bacterial infections.

Colistimethate Sodium is primarily used to treat serious bacterial infections, particularly those caused by gram-negative bacteria. It is often considered when other antibiotics are ineffective. The medication works by disrupting the bacterial cell membrane, leading to cell death. Colistimethate Sodium 150 mg/4mL is formulated for intramuscular or intravenous administration, providing a targeted approach to combating resistant infections.

Common effects of Colistimethate Sodium may include localized reactions at the injection site, such as pain or swelling. Systemic effects can include nephrotoxicity and neurotoxicity, though these are generally dose-dependent. Patients should monitor for any unusual symptoms and consult their healthcare provider if concerns arise.

Colistimethate Sodium should be handled with care, ensuring proper reconstitution and administration techniques. It is essential to follow healthcare provider instructions for dosage and frequency. Patients with pre-existing kidney conditions should use this medication cautiously, as it may affect renal function. Always store the medication as directed to maintain its efficacy.

Colistimethate Sodium may interact with other medications, particularly those that are nephrotoxic or neurotoxic. It is important to inform healthcare providers about all current medications to avoid potential adverse interactions. Alcohol and certain supplements may also influence the effectiveness or safety of Colistimethate Sodium, so it is advisable to discuss these with a healthcare professional.